Currently out of the existing stock ratings of Kalpit Patel, 68 are a BUY (73.91%), 24 are a HOLD (26.09%).

Kalpit Patel

Work Performance Price Targets & Ratings Chart

Analyst Kalpit Patel, currently employed at B. RILEY, carries an average stock price target met ratio of 34.77% that have a potential upside of 65.15% achieved within 138 days.

Kalpit Patel’s has documented 181 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GERN, Geron at 27-Feb-2025.

Wall Street Analyst Kalpit Patel

Analyst best performing recommendations are on GERN (GERON).
The best stock recommendation documented was for GERN (GERON) at 2/27/2025. The price target of $2 was fulfilled within 1 day with a profit of $0.37 (15.61%) receiving and performance score of 156.12.

Average potential price target upside

BCYC Bicycle Therapeutics Ltd INFI Infinity Pharmaceuticals INKT Mink Therapeutics KYMR Kymera Therapeutics MGTA Magenta Therapeutics RIGL Rigel Pharmaceuticals FBRX Forte Biosciences ALLO Allogene Therapeutics ENTX Entera Bio Ltd INAB In8bio  VINC Vincerx Pharma MRTX Mirati Ther DERM Journey Medical Corp GERN Geron VRDN Viridian Therapeutics SNDX Syndax Pharmaceuticals LBPH Longboard Pharmaceuticals CRBP Corbus Pharmaceuticals PDSB PDS Biotechnology Corp VSTM Verastem

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$26

$15.03 (137.01%)

$26

5 days ago
(26-Feb-2025)

1/11 (9.09%)

$14.68 (129.68%)

174

Buy

$30

$19.03 (173.47%)

$32

5 days ago
(26-Feb-2025)

0/18 (0%)

$18.68 (165.02%)

Buy

$33

$22.03 (200.82%)

$33

5 days ago
(26-Feb-2025)

1/14 (7.14%)

$21.68 (191.52%)

83

Hold

$17

$6.03 (54.97%)

$28

2 months 15 days ago
(16-Dec-2024)

1/8 (12.5%)

$1.88 (12.43%)

12

Buy

$35

$24.03 (219.05%)

$35

4 months 2 days ago
(01-Nov-2024)

0/2 (0%)

$12.29 (54.12%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Kalpit Patel is most bullish on?

Potential upside of $32.67 has been obtained for CRBP (CORBUS PHARMACEUTICALS)

Which stock is Kalpit Patel is most reserved on?

Potential downside of -$14.98 has been obtained for LBPH (LONGBOARD PHARMACEUTICALS)

What Year was the first public recommendation made by Kalpit Patel?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?